Target intelligence / Profile preview

Alpha- and gamma-adaptin-binding protein (AAGAB)

Target
AAGAB
Molecular classification
Other (assembly chaperone for adaptor complexes)
01

Overview

Alpha- and gamma-adaptin-binding protein (AAGAB) is a 34 kDa cytosolic protein found in most mammalian cells, characterized by two key regions: an N-terminal G-protein-like domain and a C-terminal dimerization domain (CTD). Its canonical function is as an assembly chaperone that facilitates the formation of AP-1 and AP-2 adaptor complexes, which are required for sorting proteins in clathrin-coated vesicle trafficking. AAGAB first exists as a homodimer; upon engaging AP-1 or AP-2 subunits (specifically the gamma subunit of AP-1, or the alpha subunit of AP-2), it dissociates into monomers to stabilize these subunits and enable complex assembly. Mutations in AAGAB, often leading to truncation and loss of the CTD, cause punctate palmoplantar keratoderma type I, a genetic skin disease characterized by hyperkeratotic lesions on palms and soles. AAGAB does not act as a classical therapeutic target (e.g., receptor, enzyme, transporter) and there are currently no known pharmacological agents or clinical biomarkers directly associated with its activity.

Other names
Alpha- and gamma-adaptin-binding protein p34AAGABFLJ11506p34KPPP1PPKP1PPKP1APunctate palmoplantar keratoderma type I
02

Biological functions

Protein complex assembly/stabilizationClathrin-mediated membrane traffickingRegulation of cell proliferation (via receptor tyrosine kinase endocytosis, e.g., EGFR)
03

Disease associations

Genetic disease (punctate palmoplantar keratoderma type I)Epidermal hyperproliferationMay impact additional skin diseases via trafficking dysfunction

Beyond the preview

Go deeper on Alpha- and gamma-adaptin-binding protein (AAGAB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha- and gamma-adaptin-binding protein (AAGAB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call